536 related articles for article (PubMed ID: 18473255)
1. Antipsychotic induced weight gain in schizophrenia:mechanisms and management.
Rege S
Aust N Z J Psychiatry; 2008 May; 42(5):369-81. PubMed ID: 18473255
[TBL] [Abstract][Full Text] [Related]
2. Management of weight gain in patients with schizophrenia.
Aquila R
J Clin Psychiatry; 2002; 63 Suppl 4():33-6. PubMed ID: 11913674
[TBL] [Abstract][Full Text] [Related]
3. Second-generation antipsychotic use in schizophrenia and associated weight gain: a critical review and meta-analysis of behavioral and pharmacologic treatments.
Das C; Mendez G; Jagasia S; Labbate LA
Ann Clin Psychiatry; 2012 Aug; 24(3):225-39. PubMed ID: 22860242
[TBL] [Abstract][Full Text] [Related]
4. Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives.
Baptista T; Kin NM; Beaulieu S; de Baptista EA
Pharmacopsychiatry; 2002 Nov; 35(6):205-19. PubMed ID: 12518268
[TBL] [Abstract][Full Text] [Related]
5. Schizophrenia, obesity, and antipsychotic medications: what can we do?
Citrome L; Vreeland B
Postgrad Med; 2008 Jul; 120(2):18-33. PubMed ID: 18654065
[TBL] [Abstract][Full Text] [Related]
6. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.
Poulin MJ; Chaput JP; Simard V; Vincent P; Bernier J; Gauthier Y; Lanctôt G; Saindon J; Vincent A; Gagnon S; Tremblay A
Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270
[TBL] [Abstract][Full Text] [Related]
7. Metabolic risk during antipsychotic treatment.
Newcomer JW
Clin Ther; 2004 Dec; 26(12):1936-46. PubMed ID: 15823759
[TBL] [Abstract][Full Text] [Related]
8. [Weight gain during treatment with antipsychotics: clinical relevance, pathophysiology, and therapeutical strategies].
Himmerich H; Schuld A; Pollmächer T
Psychiatr Prax; 2004 Nov; 31 Suppl 2():S233-7. PubMed ID: 15586316
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic options for weight management in schizophrenic patients treated with atypical antipsychotics].
Cordes J; Sinha-Röder A; Kahl KG; Malevani J; Thuenker J; Lange-Asschenfeldt C; Hauner H; Agelink MW; Klimke A
Fortschr Neurol Psychiatr; 2008 Dec; 76(12):703-14. PubMed ID: 18924059
[TBL] [Abstract][Full Text] [Related]
10. The clinical implications of weight gain in schizophrenia.
Kurzthaler I; Fleischhacker WW
J Clin Psychiatry; 2001; 62 Suppl 7():32-7. PubMed ID: 11346194
[TBL] [Abstract][Full Text] [Related]
11. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.
Basile VS; Masellis M; McIntyre RS; Meltzer HY; Lieberman JA; Kennedy JL
J Clin Psychiatry; 2001; 62 Suppl 23():45-66. PubMed ID: 11603885
[TBL] [Abstract][Full Text] [Related]
12. Schizophrenia and obesity: impact of antipsychotic medications.
Wirshing DA
J Clin Psychiatry; 2004; 65 Suppl 18():13-26. PubMed ID: 15600381
[TBL] [Abstract][Full Text] [Related]
13. Strategies for dosing and switching antipsychotics for optimal clinical management.
Buckley PF; Correll CU
J Clin Psychiatry; 2008; 69 Suppl 1():4-17. PubMed ID: 18484804
[TBL] [Abstract][Full Text] [Related]
14. The role of lifestyle interventions and weight management in schizophrenia.
Bushe C; Haddad P; Peveler R; Pendlebury J
J Psychopharmacol; 2005 Nov; 19(6 Suppl):28-35. PubMed ID: 16280335
[TBL] [Abstract][Full Text] [Related]
15. Psychiatric medication-induced obesity: a review.
Schwartz TL; Nihalani N; Jindal S; Virk S; Jones N
Obes Rev; 2004 May; 5(2):115-21. PubMed ID: 15086865
[TBL] [Abstract][Full Text] [Related]
16. Management of atypical antipsychotic drug-induced weight gain: focus on metformin.
Miller LJ
Pharmacotherapy; 2009 Jun; 29(6):725-35. PubMed ID: 19476423
[TBL] [Abstract][Full Text] [Related]
17. [Metabolic risk during antipsychotic treatment in patients with schizophrenia].
Rzewuska M
Psychiatr Pol; 2007; 41(4):457-72. PubMed ID: 18046977
[TBL] [Abstract][Full Text] [Related]
18. Switching antipsychotics as a treatment strategy for antipsychotic-induced weight gain and dyslipidemia.
Weiden PJ
J Clin Psychiatry; 2007; 68 Suppl 4():34-9. PubMed ID: 17539698
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.
Ellinger LK; Ipema HJ; Stachnik JM
Ann Pharmacother; 2010 Apr; 44(4):668-79. PubMed ID: 20233913
[TBL] [Abstract][Full Text] [Related]
20. Weight change with atypical antipsychotics in the treatment of schizophrenia.
Haddad P
J Psychopharmacol; 2005 Nov; 19(6 Suppl):16-27. PubMed ID: 16280334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
